[1] |
Katritzky, A.R.; Rees, C.W. Comprehensive Heterocyclic Chemistry., (1st ed. ), 1984, |
[2] |
Katritzky, A.R.; Rees, C.W.; Scriven, E.F.V. Comprehensive Heterocyclic Chemistry., (2nd ed. ), 1996, |
[3] |
Balaban, A.T.; Oniciu, D.C.; Katritzky, A.R. Aromaticity as a cornerstone of heterocyclic chemistry. Chem. Rev., 2004, 104(5), 2777-2812.
|
[4] |
Martins, M.A.P.; Cunico, W.; Pereira, C.M.P.; Flores, A.F.C.; Bonacorso, H.G.; Zanatta, N. 4-Alkoxy-1,1,1- Trichloro-3-Alken-2-ones: Preparation and applications in heterocyclic synthesis. Curr. Org. Synth., 2004, 1, 391-403.
|
[5] |
Druzhinin, S.V.; Balenkova, E.S.; Nenajdenko, V.G. Recent advances in the chemistry of α,β-unsaturated trifluoromethylketones. Tetrahedron, 2007, 63, 7753-7808.
|
[6] |
Ghose, A.K.; Viswanadhan, V.N.; Wendoloski, J.J. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J. Comb. Chem., 1999, 1(1), 55-68.
|
[7] |
Xu, J.; Stevenson, J. Drug-like index: A new approach to measure drug-like compounds and their diversity. J. Chem. Inf. Comput. Sci., 2000, 40(5), 1177-1187.
|
[8] |
Marcos, C.F.; Polo, C.; Rakitin, O.A.; Rees, C.W.; Torroba, T. From Hunig’s Base to Bis([1,2]dithiolo)-[1,4]thiazines in One Pot: The Fast Route to Highly Sulfurated Heterocycles. Angew. Chem., 1997, 36, 281-283.
|
[9] |
Marcos, C.F.; Polo, C.; Rakitin, O.A.; Rees, C.W.; Torroba, T. One-pot synthesis and chemistry of bis[1,2]dithiolopyrroles. Chem. Commun. (Camb.), 1997, 9, 879-880.
|
[10] |
Marcos, C.F.; Rakitin, O.A.; Rees, C.W.; Torroba, T.; White, A.J.P.; Williams, D.J. Tertiary amine-S2Cl2 chemistry: interception of reaction intermediates. Chem. Commun. (Camb.), 1998, 4, 453-454.
|
[11] |
Marcos, C.F.; Rakitin, O.A.; Rees, C.W.; Torroba, T.; White, A.J.P.; Williams, D.J. Bis[1,2]dithiolo[3,4-b][4′,3′-e][1,4]thiazine-3,5-dione, a planar 1,4-thiazine. Chem. Commun. (Camb.), 1999, 1, 29-30.
|
[12] |
García-Valverde, M.; Pascual, R.; Torroba, T. Synthesis, chemistry, and dynamic NMR study of new atropisomeric 4-dialkylamino-5-chloro-1,2-dithiole-3-thiones. Org. Lett., 2003, 5(6), 929-932.
|
[13] |
Kappe, C.O. 100 years of the biginelli dihydropyrimidine synthesis. Tetrahedron, 1993, 49, 6937-6963.
|
[14] |
Dandia, A.; Khaturia, S.; Sarawgi, P.; Jain, A. One-Pot Three-Component Condensation Reaction in Water: An Efficient and Improved Procedure for the Synthesis of Pyrimido[2,1-b]benzothiazoles. Phosphorous Sulphur, 2007, 182, 2529-2539.
|
[15] |
Varma, R.S. Solvent-free organic syntheses using supported reagents and microwave irradiation. Green Chem., 1999, 1, 43-45.
|
[16] |
Atwal, K.S.; Swanson, B.N.; Unger, S.E.; Floyd, D.M.; Moreland, S.; Hedberg, A.; O’Reilly, B.C. Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents. J. Med. Chem., 1991, 34(2), 806-811.
|
[17] |
Rovnyak, G.C.; Atwal, K.S.; Hedberg, A.; Kimball, S.D.; Moreland, S.; Gougoutas, J.Z.; O’Reilly, B.C.; Schwartz, J.; Malley, M.F. Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents. J. Med. Chem., 1992, 35(17), 3254-3263.
|
[18] |
Khania, F.L.; Sillinietse, G.O.; Ozel, G. Dabur.; Ozel, Ya. Ya.; Yakimenis, A. A. Khim.Pharm. Zh, 1998, 78, 1321. |
[19] |
Cho, H.; Ueda, M.; Shima, K.; Mizuno, A.; Hayashimatsu, M.; Ohnaka, Y.; Takeuchi, Y.; Hamaguchi, M.; Aisaka, K.; Hidaka, T. Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity. J. Med. Chem., 1989, 32(10), 2399-2406.
|
[20] |
Belema, M.; Bunker, A.; Nguyen, V.; Beaulieu, F.; Ouellet, C.; Marinier, A.; Roy, S.; Yung, X.; Zhang, Y.; Zuci, C. PCT Int. Appl. WO 2003084, Through. Chem. Abstr., 2003, 139337987x |
[21] |
Pirisino, R.; Bianchini, F.; Banchelli, G.; Ignesti, G.; Raimondi, L.; Pecori-Vettori, L.; Rafanelli, D. Pharmacological activity of FPP028 (2-phenylpyrazolo-4-ethyl-4,7-dihydro [1,5a]pyrimidin-7-one) a new non-steroid anti-inflammatory agent. Pharmacol. Res. Commun., 1986, 18(3), 241-256.
|
[22] |
Modica, M.; Santagati, M.; Santagati, A.; Cutuli, V.; Mangano, N.; Caruso, A. Synthesis of new [1,3,4]thiadiazolo[3,2-a]thieno[2,3-d]pyrimidinone derivatives with antiinflammatory activity. Pharmazie, 2000, 55(7), 500-502.
|
[23] |
Cenicola, M.L.; Donnoli, D.; Stella, L.; De Paola, C.; Costantino, M.; Abignente, E.; Arena, F.; Luraschi, E.; Saturnino, C. Research on heterocyclic compounds. Antiinflammatory activity of some imidazo(1,2-c)pyrimidine derivatives. Pharmacol. Res., 1990, 22(Suppl. 3), 80-81.
|
[24] |
Nargund, L.V.G.; Badiger, V.V.; Yarnal, S.M. Synthesis and antimicrobial and anti-inflammatory activities of substituted 2-mercapto-3-(N-aryl)pyrimido[5,4-c]cinnolin-4-(3H)-ones. J. Pharm. Sci., 1992, 81(4), 365-366.
|
[25] |
Cottam, H.B.; Wasson, D.B.; Shih, H.C.; Raychaudhuri, A.; Di Pasquale, G.; Carson, D.A. New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation. J. Med. Chem., 1993, 36(22), 3424-3430.
|
[26] |
Bruni, F.; Costanzo, A.; Selleri, S.; Guerrini, G.; Fantozzi, R.; Pirisino, R.; Brunelleschi, S. Synthesis and study of the anti-inflammatory properties of some pyrazolo[1,5-a]pyrimidine derivatives. J. Pharm. Sci., 1993, 82(5), 480-486.
|
[27] |
Tozkoparan, B.; Ertan, M.; Kelicen, P.; Demirdamar, R. Synthesis and anti-inflammatory activities of some thiazolo[3,2-a]pyrimidine derivatives. Farmaco, 1999, 54(9), 588-593.
|
[28] |
Lee, C.H.; Jiang, M.; Cowart, M.; Gfesser, G.; Perner, R.; Kim, K.H.; Gu, Y.G.; Williams, M.; Jarvis, M.F.; Kowaluk, E.A.; Stewart, A.O.; Bhagwat, S.S. Discovery of 4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine, an orally active, non-nucleoside adenosine kinase inhibitor. J. Med. Chem., 2001, 44(13), 2133-2138.
|
[29] |
Boyle, D.L.; Kowaluk, E.A.; Jarvis, M.F.; Lee, C.H.; Bhagwat, S.S.; Williams, M.; Firestein, G.S. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. J. Pharmacol. Exp. Ther., 2001, 296(2), 495-500.
|
[30] |
Molina, P.; Aller, E.; Lorenzo, A.; López-Cremades, P.; Rioja, I.; Ubeda, A.; Terencio, M.C.; Alcaraz, M.J. Solid-phase synthesis and inhibitory effects of some pyrido[1,2-c]pyrimidine derivatives on leukocyte formations and experimental inflammation. J. Med. Chem., 2001, 44(6), 1011-1014.
|
[31] |
Vidal, A.; Ferrándiz, M.L.; Ubeda, A.; Acero-Alarcon, A.; Sepulveda-Arques, J.; Alcaraz, M.J. Effect of some hexahydroimidazo[1,2-c]pyrimidines in inflammatory responses involving leucocytes and macrophages. J. Pharm. Pharmacol., 2001, 53(10), 1379-1385.
|
[32] |
Bruno, O.; Brullo, C.; Ranise, A.; Schenone, S.; Bondavalli, F.; Barocelli, E.; Ballabeni, V.; Chiavarini, M.; Tognolini, M.; Impicciatore, M. Synthesis and pharmacological evaluation of 2,5-cycloamino-5H-[1]benzopyrano[4,3-d]pyrimidines endowed with in vitro antiplatelet activity. Bioorg. Med. Chem. Lett., 2001, 11(11), 1397-1400.
|
[33] |
Bahekar, S.S.; Shinde, D.B. Synthesis and anti-inflammatory activity of some [2-amino-6-(4-substituted aryl)-4-(4-substituted phenyl)-1,6-dihydropyrimidine-5-yl]-acetic acid derivatives. Acta Pharm., 2003, 53(3), 223-229.
|
[34] |
Sawhney, S.N.; Bhutani, S. Dharamvir. Synthesis of some 2 - (2 - Benzothiazolyl) - 6 2 - (2 - Benzimidazolyl) - 6 - aryl -4,5- dihydro - 3 (211 -) pyridazinones as potential anti-flamatory agents. Indian J. Chem., 1987, 26B, 348-350. |
[35] |
Singh, S.P.; Vaid, R.K. Synthesis and anti-inflammatory activity of some 2-(4′-butyl-3′,5′-dimethylpyrazol-1‘yl)-6-substituted benzothiazoles and 4-butyl-1-(6’-substituted-2′-benzothiazolyl)-3-methylpyrazol-5-ones. Indian J. Chem., 1986, 25B, 288-291. |
[36] |
Paramashivappa, R.; Phani Kumar, P.; Subba Rao, P.V.; Srinivasa Rao, A. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors. Bioorg. Med. Chem. Lett., 2003, 13(4), 657-660.
|
[37] |
Dogruer, D.S.; Unlu, S.; Sahin, M.F.; Yesilada, E. Synthesis of (2-benzothiazolone-3-yl and 2-benzothiazolone-3-yl) acetic acid derivatives and Evaluation of their Antinocioceptive and Anti-inflammatory Activity. Farmaco, 1998, 53, 80.
|
[38] |
Diouf, O.; Depreux, P.; Lesieur, D.; Poupaert, J.H.; Caignard, D.H. Synthesis and evaluation of new 2-piperazinylbenzothiazoles with high 5-HT1A and 5-HT3 affinities. Eur. J. Med. Chem., 1995, 30, 715-719.
|
[39] |
Nagarajan, S.R.; De Crescenzo, G.A.; Getman, D.P.; Lu, H.F.; Sikorski, J.A.; Walker, J.L.; McDonald, J.J.; Houseman, K.A.; Kocan, G.P.; Kishore, N.; Mehta, P.P.; Funkes-Shippy, C.L.; Blystone, L. Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease. Bioorg. Med. Chem., 2003, 11(22), 4769-4777.
|
[40] |
Jimonet, P.; Audiau, F.; Barreau, M.; Blanchard, J.C.; Boireau, A.; Bour, Y.; Coléno, M.A.; Doble, A.; Doerflinger, G.; Huu, C.D.; Donat, M.H.; Duchesne, J.M.; Ganil, P.; Guérémy, C.; Honor, E.; Just, B.; Kerphirique, R.; Gontier, S.; Hubert, P.; Laduron, P.M.; Le Blevec, J.; Meunier, M.; Miquet, J.M.; Nemecek, C.; Mignani, S. Riluzole series. Synthesis and in vivo “antiglutamate” activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines. J. Med. Chem., 1999, 42(15), 2828-2843.
|
[41] |
Siddiqui, N.; Pandeya, S.N.; Sen, A.P.; Singh, G.S. A series of benzothiazolyl guanidiness were synthesized for there significant anticonvulsant actinity. Pharmak Eftiki, 1992, 4, 121. |
[42] |
Singh, S.P.; Misra, R.S.; Parmar, S.S.; Brumleve, S.J. Synthesis of 2-(4-arylthiosemicarbazidocarbonylthio)benzthiazoles and their monoamine oxidase inhibitory and anticonvulsant properties. J. Pharm. Sci., 1975, 64(7), 1245-1247.
|
[43] |
Ucar, H.; Van derpoorten, K.; Cacciaguerra, S.; Spampinato, S.; Stables, J.P.; Depovere, P.; Isa, M.; Masereel, B.; Delarge, J.; Poupaert, J.H. Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives. J. Med. Chem., 1998, 41(7), 1138-1145.
|
[44] |
Oketani, K.; Nagakura, N.; Harada, K.; Inoue, T. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production. Eur. J. Pharmacol., 2001, 422(1-3), 209-216.
|
[45] |
Sreenivasa, M.V.; Nagappa, A.N.; Nargund, L.V.G. Various benzothiazolotriazole derivatives possess good microbial activity. Indian J. Heterocycl. Chem., 1998, 8, 23-27. |
[46] |
Gopkumar, P.; Shivakumar, B.; Jayachandran, E.; Nagappa, A.N.; Nargund, L.V.G.; Gurupadaiah, B.M. Synthesis and biological activity of 6-fluoro-7-(substituted)-(2-Np-anilino sulphonamido) benzothiazoles. Indian J. Heterocycl. Chem., 2001, 11, 39-42. |
[47] |
Ojha, K.G.; Jaisinghani, N.; Tahiliani, H. Synthesis and biological activity of N-phenyl-3-methyl-4-(benzothiazo-2′-carboxamido)-5-aryl-2-pyrazolines. J. Indian Chem. Soc., 2002, 79, 191. |
[48] |
Bhawsar, S.B.; Mane, D.V.; Sinde, D.B.; Shingare, M.S.; Deokate, A.S.; Congwane, L.V. Synthesis of some 8-[6′-substituted-1′, 3′-benzothiazol-2′-yl) amino methyl] substituted hydroxyl coumarins and Evaluation of their antibacterial activity. Indian J. Heterocycl. Chem., 1996, 8, 23-26. |
[49] |
Barde, A.R.; Barsu, K.H.; Bobade, A.S. Indian Drugs, 1998, 35, 554. |
[50] |
O’Brien, S.E.; Browne, H.L.; Bradshaw, T.D.; Westwell, A.D.; Stevens, M.F.; Laughton, C.A. Antitumor benzothiazoles. Frontier molecular orbital analysis predicts bioactivation of 2-(4-aminophenyl)benzothiazoles to reactive intermediates by cytochrome P4501A1. Org. Biomol. Chem., 2003, 1(3), 493-497.
|
[51] |
Trapani, V.; Patel, V.; Leong, C.O.; Ciolino, H.P.; Yeh, G.C.; Hose, C.; Trepel, J.B.; Stevens, M.F.; Sausville, E.A.; Loaiza-Pérez, A.I. DNA damage and cell cycle arrest induced by 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole (5F 203, NSC 703786) is attenuated in aryl hydrocarbon receptor deficient MCF-7 cells. Br. J. Cancer, 2003, 88(4), 599-605.
|
[52] |
Monks, A.; Harris, E.; Hose, C.; Connelly, J.; Sausville, E.A. Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole. Mol. Pharmacol., 2003, 63(3), 766-772.
|
[53] |
Bradshaw, T.D.; Trapani, V.; Vasselin, D.A.; Westwell, A.D. The aryl hydrocarbon receptor in anticancer drug discovery: friend or foe? Curr. Pharm. Des., 2002, 8(27), 2475-2490.
|
[54] |
Bradshaw, T.D.; Bibby, M.C.; Double, J.A.; Fichtner, I.; Cooper, P.A.; Alley, M.C.; Donohue, S.; Stinson, S.F.; Tomaszewjski, J.E.; Sausville, E.A.; Stevens, M.F. Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles. Mol. Cancer Ther., 2002, 1(4), 239-246.
|
[55] |
Shi, D.F.; Bradshaw, T.D.; Chua, M.S.; Westwell, A.D.; Stevens, M.F.G. Antitumour benzothiazoles. Part 15: The synthesis and physico-chemical properties of 2-(4-aminophenyl)benzothiazole sulfamate salt derivatives. Bioorg. Med. Chem. Lett., 2001, 11(8), 1093-1095.
|
[56] |
Hutchinson, I.; Chua, M.S.; Browne, H.L.; Trapani, V.; Bradshaw, T.D.; Westwell, A.D.; Stevens, M.F.G. Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles. J. Med. Chem., 2001, 44(9), 1446-1455.
|
[57] |
Gineinah, M.M.M. 6-, 7- And 8-(5-Aryl-1-Phenyl-2-Pyrazolin-3-ly)Imidazo- and Pyrimido[2,1-b]Benzothiazoles as Novel Antoconvulsant Agents. Sci. Pharm., 2001, 69(1), 53-61.
|
[58] |
Russo, F.; Romeo, G.; Santagati, N.A.; Caruso, A.; Cutuli, V.; Amore, D. Synthesis of new thienopyrimidobenzothiazoles and thienopyrimidobenzoxazoles with analgesic and antiinflammatory properties. Eur. J. Med. Chem., 1994, 29, 569-578.
|
[59] |
Zimmermann, J.; Bauer, H.H.; Hohorst, H.J.; Voelcker, G. Synthesis of 1-aldofosfamide-perhydrothiazines. Arzneimittelforschung, 2000, 50(9), 843-847.
|
[60] |
Landreau, C.; Deniaud, D.; Evain, M.; Reliquet, A.; Meslin, J.C. Efficient regioselective synthesis of triheterocyclic compounds: imidazo[2,1-b]benzothiazoles, pyrimido[2,1-b]benzothiazolones and pyrimido[2,1-b]benzothiazoles. J. Chem. Soc., Perkin Trans., 2002, 1, 741-745.
|
[61] |
Ai, J.; Wang, X.; Wahe, H.; Fomum, Z.T.; Sterner, O.; Nielsen, M.; Witt, M.R. 2-Oxo-2H-Pyrimido[2,1-b]benzothiazoles inhibit brain benzodiazepine receptor binding in vitro. Pharmacology, 2000, 60(4), 175-178.
|
[62] |
Trapani, G.; Franco, M.; Latrofa, A.; Carotti, A.; Genchi, G.; Serra, M.; Biggio, G.; Liso, M. Synthesis and benzodiazepine receptor binding of some imidazoand pyrimido[2,1-b]benzothiazoles. Eur. J. Med. Chem., 1996, 31, 575-587.
|
[63] |
Gupta, R.R. Synthetic and spectral investigation of fluorinated phenothiazines and 4H-1,4-benzothiazines as potent anticancer agents. J. Fluor. Chem., 1993, 62, 191-200.
|
[64] |
Gupta, R.R.; Kumar, M.; Gupta, V. Heterocyclic Chemistry, (1st ed. ), 1998,
|
[65] |
Gupta, R.R.; Kumar, M.; Gupta, V. Heterocyclic Chemistry., (2nd ed. ), 1999,
|
[66] |
Varga, J.M.; Kalchschmid, G.; Klein, G.F.; Fritsch, P. Mechanism of allergic cross-reactions-I. Multispecific binding of ligands to a mouse monoclonal anti-DNP IgE antibody. Mol. Immunol., 1991, 28(6), 641-654.
|
[67] |
Metwally. M.A.; El-Hossini, M.S.; El-Alblak F.Z.; Khalil, A.M. Pharmazie., Synthesis of condensed heterocycles from 3-aryl-2,4-dicarbethoxy-5-methylcyclohexanones and their testing for antimicrobial activity. 1992, 47(5), 336-339. |
[68] |
Li, H.; Dryhurst, G. Irreversible inhibition of mitochondrial complex I by 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1): A putative nigral endotoxin of relevance to Parkinson’s disease. J. Neurochem., 1997, 69(4), 1530-1541.
|
[69] |
Kobayashi, T.; Strobeck, M.; Schwartz, A.; Mori, Y. Inhibitory effects of a new neuroprotective diltiazem analogue, T-477, on cloned brain Ca2+ channels expressed in Xenopus oocytes. Eur. J. Pharmacol., 1997, 332(3), 313-320.
|
[70] |
Schreiber, S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science, 2000, 287(5460), 1964-1969.
|
[71] |
Teague, S.J.; Davis, A.M.; Leeson, P.D.; Oprea, T. The design of leadlike combinatorial libraries. Angew. Chem. Int. Ed. Engl., 1999, 38(24), 3743-3748.
|
[72] |
Armstrong, R.W.; Combs, A.P.; Tempest, P.A.; Brown, S.D.; Keating, T.A. Multiple-component condensation strategies for combinatorial library synthesis. Acc. Chem. Res., 1996, 29, 123-131.
|
[73] |
Cecchetti, V.; Schiaffella, F.; Tabarrini, O.; Fravolini, A. (1,4-Benzothiazinyloxy)alkylpiperazine derivatives as potential antihypertensive agents. Bioorg. Med. Chem. Lett., 2000, 10(5), 465-468.
|
[74] |
Turk, C.F.; Egli, P.; Krapcho, J. Synthesis and antiinflammatory activity of the sulfoxides of 4-(3-(dimethylamino)propyl)-3,4-dihydro-2-(1-hydroxyethyl)-3-phenyl-2h -1,4-benzothiazine. J. Heterocycl. Chem., 1977, 14, 1135-1137.
|
[75] |
Kanda, A.; Hashimoto, H. Effects of semotiadil fumarate, a novel calcium antagonist, on blood pressure and heart rate in conscious spontaneously hypertensive rats. Jpn. J. Pharmacol., 1993, 63(1), 121-124.
|
[76] |
Sugimoto, Y.; Tarumi, T.; Zhao, Q.E.; Fujii, Y.; Kamei, C. Effects of antiallergic drugs on histamine release from rat peritoneal mast cells induced by bradykinin. Methods Find. Exp. Clin. Pharmacol., 1998, 20(6), 457-462.
|
[77] |
King, D.J.; Wager, E. Haematological safety of antipsychotic drugs. J. Psychopharmacol. (Oxford), 1998, 12(3), 283-288.
|
[78] |
Williams, P.I.; Smith, M. An assessment of prochlorperazine buccal for the prevention of nausea and vomiting during intravenous patient-controlled analgesia with morphine following abdominal hysterectomy. Eur. J. Anaesthesiol., 1999, 16(9), 638-645.
|
[79] |
Platonov, I.A. [The effect of neuroleptics on blood proteins during development of toxic cerebral edema-brain swelling]. Vopr. Med. Khim., 1995, 41(1), 27-29.
|
[80] |
Wolfe, S.; Zhang, C.; Johnston, B.D.; Kim, C.K. Synthesis of the stereoisomers of a novel antibacterial agent and interpretation of their relative activities in terms of a theoretical model of the penicillin receptor. Can. J. Chem., 1994, 72, 1066-1075.
|
[81] |
Kale, S.B.; Karale, B.K. Synthesis and characterization of some important indazolyl derivatives. J. Heterocycl. Chem., 2007, 44(2), 289-301.
|
[82] |
Aiello, A.; Fattorusso, E.; Luciano, P.; Menna, M.; Esposito, G.; Iuvone, T.; Pala, D. Conicaquinones A and B, two novel cytotoxic terpene quinones from the mediterranean ascidian Aplidium conicum. Eur. J. Org. Chem., 2003, 898-900.
|
[83] |
Ma, Y-T.; Huang, M-C.; Hsu, F-L.; Chang, H-F. Thiazinedione from Xanthium strumarium. Phytochemistry, 1998, 48, 1083-1085.
|
[84] |
Stoodley, R.J. Katritzky, A. R. Advances in Heterocyclic Chemistry., (1st ed. ), 1979, |
[85] |
Cecchetti, V.; Calderone, V.; Tabarrini, O.; Sabatini, S.; Filipponi, E.; Testai, L.; Spogli, R.; Martinotti, E.; Fravolini, A. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers. J. Med. Chem., 2003, 46(17), 3670-3679.
|
[86] |
Matsuoka, H.; Ohi, N.; Mihara, M.; Suzuki, H.; Miyamoto, K.; Maruyama, N.; Tsuji, K.; Kato, N.; Akimoto, T.; Takeda, Y.; Yano, K.; Kuroki, T. Antirheumatic agents: Novel methotrexate derivatives bearing a benzoxazine or benzothiazine moiety. J. Med. Chem., 1997, 40(1), 105-111.
|
[87] |
Calderone, V.; Spogli, R.; Martelli, A.; Manfroni, G.; Testai, L.; Sabatini, S.; Tabarrini, O.; Cecchetti, V. Novel 1,4-benzothiazine derivatives as large conductance Ca2+-activated potassium channel openers. J. Med. Chem., 2008, 51(16), 5085-5092.
|
[88] |
Wang, Z.; Yuan, Y.; Chen, Y.; Sun, G.; Wu, X.; Zhang, S.; Han, C.; Wang, G.; Li, L.; Liu, G. Parallel solution-phase synthesis of 4H-benzo[1,4]thiazin-3-one and 1,1-dioxo-1,4-dihydro-2H-1lambda6-benzo[1,4]thiazin-3-one derivatives from 1,5-difluoro-2,4-dinitrobenzene. J. Comb. Chem., 2007, 9(4), 652-660.
|
[89] |
Cecchetti, V.; Calderone, V.; Tabarrini, O.; Sabatini, S.; Filipponi, E.; Testai, L.; Spogli, R.; Fravolini, A. Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers. J. Med. Chem., 2005, 48, 6766.
|
[90] |
Marchetti, C.; Ulisse, S.; Bruscoli, S.; Russo, F.P.; Migliorati, G.; Schiaffella, F.; Cifone, M.G.; Riccardi, C.; Fringuelli, R. Induction of apoptosis by 1,4-benzothiazine analogs in mouse thymocytes. J. Pharmacol. Exp. Ther., 2002, 300(3), 1053-1062.
|
[91] |
Kaneko, T.; Clark, R.S.; Ohi, N.; Kawahara, T.; Akamatsu, H.; Ozaki, F.; Kamada, A.; Okano, K.; Yokohama, H.; Muramoto, K.; Ohkuro, M.; Takenaka, O.; Kobayashi, S. Inhibitors of adhesion molecules expression; the synthesis and pharmacological properties of 10H-pyrazino[2,3-b][1,4]benzothiazine derivatives. Chem. Pharm. Bull. (Tokyo), 2002, 50(7), 922-929.
|
[92] |
Kaneko, T.; Clark, R.S.; Ohi, N.; Ozaki, F.; Kawahara, T.; Kamada, A.; Okano, K.; Yokohama, H.; Ohkuro, M.; Muramoto, K.; Takenaka, O.; Kobayashi, S. Piperidine carboxylic acid derivatives of 10H-pyrazino[2,3-b][1,4]benzothiazine as orally-active adhesion molecule inhibitors. Chem. Pharm. Bull. (Tokyo), 2004, 52(6), 675-687.
|
[93] |
Chia, E.W.; Pearce, A.N.; Berridge, M.V.; Larsen, L.; Perry, N.B.; Sansom, C.E.; Godfrey, C.A.; Hanton, L.R.; Lu, G.L.; Walton, M.; Denny, W.A.; Webb, V.L.; Copp, B.R.; Harper, J.L. Synthesis and anti-inflammatory structure-activity relationships of thiazine-quinoline-quinones: inhibitors of the neutrophil respiratory burst in a model of acute gouty arthritis. Bioorg. Med. Chem., 2008, 16(21), 9432-9442.
|
[94] |
Barazarte, A.; Camacho, J.; Domínguez, J.; Lobo, G.; Gamboa, N.; Rodrigues, J.; Capparelli, M.V.; Álvarez-Larena, A.; Andujar, S.; Enriz, D.; Charris, J. Synthesis, antimalarial activity, structure-activity relationship analysis of thieno-[3,2-b]benzothiazine S,S-dioxide analogs. Bioorg. Med. Chem., 2008, 16(7), 3661-3674.
|
[95] |
Bakavoli, M.; Nikpour, M.; Rahimizadeh, M.; Saberi, M.R.; Sadeghian, H. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors. Bioorg. Med. Chem., 2007, 15(5), 2120-2126.
|
[96] |
Rathore, B.S.; Kumar, M. Synthesis of 7-chloro-5-trifluoromethyl/7-fluoro/7-trifluoromethyl-4H-1,4-benzothiazines as antimicrobial agents. Bioorg. Med. Chem., 2006, 14(16), 5678-5682.
|
[97] |
Schiaffella, F.; Macchiarulo, A.; Milanese, L.; Vecchiarelli, A.; Fringuelli, R. Novel ketoconazole analogues based on the replacement of 2,4-dichlorophenyl group with 1,4-benzothiazine moiety: design, synthesis, and microbiological evaluation. Bioorg. Med. Chem., 2006, 14(15), 5196-5203.
|
[98] |
Fringuelli, R.; Schiaffella, F.; Bistoni, F.; Pitzurra, L.; Vecchiarelli, A. Azole derivatives of 1,4-benzothiazine as antifungal agents. Bioorg. Med. Chem., 1998, 6(1), 103-108.
|
[99] |
Sheibani, H.; Islami, M.R.; Hassanpour, A.; Hosseininasab, F.A. Nucleophilic substitution of 2,2′-disulfanediyldianiline by β-keto esters and 1,3-diketones in the presence of triethylamine. ARKIVOC, 2006, 15, 68-75. |
[100] |
Sabatini, S.; Kaatz, G.W.; Rossolini, G.M.; Brandini, D.; Fravolini, A. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. J. Med. Chem., 2008, 51(14), 4321-4330.
|
[101] |
Miller, W.H.; Rouse, M.B.; Seefeld, M.A. Antibacterial agents. WO2006014580 A1, 2006. |
[102] |
Miller, W.H.; Pendrak, I.; Seefeld, M.A. Antibacterial agents. WO 2006002047 A3, 2006. |
[103] |
Hubschwerlen, C.; Surivet, J.P.; Acklin, C.Z Beta-aminoalcohol antibiotics. WO2006099884A1, 2006. |
[104] |
Singh, R.; Argade, A.; Payan, D.G.; Clough, J.; Keim, H.; Sylvain, C.; Li, H.; Bhamidipati, S. Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds. WO2004014382A1, 2004. |
[105] |
Jiang, L.; He, Y.; An, J. 2-mercapto-ethylamine cyclized hypocrellin and preparation process and usage thereof. CN1266061A, 2002. |
[106] |
Kaul, B.L.; Piastra, B.; Wolf, V. Pigments, the process of their manufacture and their use. EP 1046680A2, 2000. |
[107] |
Bur, D.; Hubschwerlen, C.; Surivet, J.P.; Zumbrunn Acklin, C. New antibiotic derivatives. WO 2006126171A2, 2006. |
[108] |
Ehara, T.; Hitomi, Y.; Konischi, K.; Masuya, K. Substituted piperidines as renin inhibitors. WO 2006125621A1, 2008. |
[109] |
Badshah, S.L.; Ahmad, N.; Ur Rehman, A.; Khan, K.; Ullah, A.; Alsayari, A.; Muhsinah, A.B.; N Mabkhot, Y. Molecular docking and simulation of Zika virus NS3 helicase. BMC Chem, 2019, 13(1), 67-74.
|
[110] |
Denny, W.A.; Copp, B.R.; Pearce, A.N.; Berridge, M.V.; Harper, J.L.; Perry, N.B.; Larsen, L.; Godfrey, C.A. Anti-inflammatory compounds. WO 2006031134A1, 2006. |
[111] |
Pierau, S.; Dale, G. Novel compounds having an anti-bacterial activity. WO 2006021448A1, 2006. |
[112] |
Strobel, H.; Nemecek, C.; Lesuisse, D.; Ruf, S.; Guessregen, St.; Lebrun, A.; Ritter, K.; Malleron, J.L. Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors. EP 1621539A1, 2006. |
[113] |
Yuji, O.; Fumihiko, A.; Akihiko, M.; Satoru, U.; Tsuguo, I. Process for the preparation of (-)-1,4-benzothiazine-2-acetic acid derivatives. WO2000076995 A1, 2000. |
[114] |
Cali, P.; Hjelmencrantz, A.; Naerum, L. Peptide deformylase inhibitors. WO 2005092872 A1 20051006, 2005. |
[115] |
Molteni, V.; He, X.; He, Y.; Kreusch, A.; Nabakka, J.; Yang, K. Bicyclic compounds and compositions as pdf inhibitors. WO 2005011611 A2 20050210, 2005. |
[116] |
Bhushan, L.B.; Bhushan, L.V.; Channaveerappa, B.A.; Shivaramayya, K.; Rajagopalan, R.; Ranjan, C. Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them. WO9920614 A1, 1999. |
[117] |
Liu, X.H.; Cui, P.; Song, B.A.; Bhadury, P.S.; Zhu, H.L.; Wang, S.F. Synthesis, structure and antibacterial activity of novel 1-(5-substituted-3-substituted-4,5-dihydropyrazol-1-yl)ethanone oxime ester derivatives. Bioorg. Med. Chem., 2008, 16(7), 4075-4082.
|
[118] |
Tanitame, A.; Oyamada, Y.; Ofuji, K.; Kyoya, Y.; Suzuki, K.; Ito, H.; Kawasaki, M.; Nagai, K.; Wachi, M.; Yamagishi, J. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity. Bioorg. Med. Chem. Lett., 2004, 14(11), 2857-2862.
|
[119] |
Velaparthi, S.; Brunsteiner, M.; Uddin, R.; Wan, B.; Franzblau, S.G.; Petukhov, P.A. 5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs. J. Med. Chem., 2008, 51(7), 1999-2002.
|
[120] |
Magedov, I.V.; Manpadi, M.; Slambrouck, S.V.; Steelant, W.F.; Rozhkova, E.; Przheval’skii, N.M.; Rogelj, S.; Kornienko, A. Discovery and investigation of antiproliferative and apoptosis-inducing properties of new heterocyclic podophyllotoxin analogues accessible by a one-step multicomponent synthesis. J. Med. Chem., 2007, 50(21), 5183-5192.
|
[121] |
Rovnyak, G.C.; Millonig, R.C.; Schwartz, J.; Shu, V. Synthesis and antiinflammatory activity of hexahydrothiopyrano[4,3-c]pyrazoles and related analogues. J. Med. Chem., 1982, 25(12), 1482-1488.
|
[122] |
Wächter, G.A.; Hartmann, R.W.; Sergejew, T.; Grün, G.L.; Ledergerber, D. Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17. J. Med. Chem., 1996, 39(4), 834-841.
|
[123] |
Armenise, D.; Trapani, G.; Arrivo, V.; Morlacchi, F. Preparation of potentially bioactive aza and thiaza polycyclic compounds containing a bridgehead nitrogen atom. Synthesis of pyrrolo[1,2,3-de]-1,4-benzothiazine derivatives. J. Heterocycl. Chem., 1990, 27, 1521-1525.
|
[124] |
Vicentini, C.B.; Mares, D.; Tartari, A.; Manfrini, M.; Forlani, G. Synthesis of pyrazole derivatives and their evaluation as photosynthetic electron transport inhibitors. J. Agric. Food Chem., 2004, 52(7), 1898-1906.
|
[125] |
Waldrep, T.W.; Beck, J.R.; Lynch, M.P.; Wright, F.L. Synthesis and herbicidal activity of 1-aryl-5-halo and 1-aryl-5- (trifluoromethyl)-1H-pyrazole-4-carboxamides. J. Agric. Food Chem., 1990, 38, 541-544.
|
[126] |
Minakata, S.; Hamada, T.; Komatsu, M.; Tsuboi, H.; Kikuta, H.; Ohshiro, Y. Synthesis and Biological Activity of 1H-Pyrrolo[2,3-b]pyridine Derivatives: Correlation between Inhibitory Activity against the Fungus Causing Rice Blast and Ionization Potential. J. Agric. Food Chem., 1997, 45, 2345-2348.
|
[127] |
Vicentini, C.B.; Romagnoli, C.; Andreotti, E.; Mares, D. Synthetic pyrazole derivatives as growth inhibitors of some phytopathogenic fungi. J. Agric. Food Chem., 2007, 55(25), 10331-10338.
|
[128] |
Li, Y.; Zhang, H.Q.; Liu, J.; Yang, X.P.; Liu, Z.J. Stereoselective synthesis and antifungal activities of (E)-alpha-(methoxyimino)benzeneacetate derivatives containing 1,3,5-substituted pyrazole ring. J. Agric. Food Chem., 2006, 54(10), 3636-3640.
|
[129] |
Mashkovskii, M.D. Lekarstvennye sredstva (Drugs), 2002, 1, 253-263. |
[130] |
a)Wijtmans, R.; Vink, M.K.S.; Schoemaker, H.E.; van Delft, F.L.; Blaauw, R.H.; Rutjes, F.P.J.T. Biological Relevance and Synthesis of C-Substituted Morpholine Derivatives. Synthesis., 2004, 641-662. and references therein. Wilkinson, M. C. Asymmetric synthesis of an aminomethyl morpholine via double allylic substitution. Tetrahedron Lett., 2005, 46, 4773.b)Lanman, B.A.; Myers, A.G. Efficient, stereoselective synthesis of trans-2,5-disubstituted morpholines. Org. Lett., 2004, 6(6), 1045-1047.
|
[131] |
Abramova, T.V.; Bakharev, P.A.; Vasilyeva, S.V.; Silnikov, V.N. Synthesis of morpholine nucleoside triphosphates. Tetrahedron Lett., 2004, 45, 4361-4364.
|
[132] |
Ito, K.; Imahayashi, Y.; Kuroda, T.; Eno, S.; Saito, B.; Katsuki, T. Palladium-catalyzed asymmetric tandem allylic substitution using chiral 2-(phosphinophenyl)pyridine ligand. Tetrahedron Lett., 2004, 45, 7277-7281.
|
[133] |
Clark, S.M.; Osborn, H.M.I. Synthetic entry to functionalised morpholines and [1,4]-oxazepanes via reductive amination reactions of carbohydrate derived dialdehydes. Tetrahedron Asymmetry, 2004, 15, 3643-3652.
|
[134] |
Brenner, E.; Baldwin, R.M.; Tamagnan, G. Asymmetric synthesis of (+)-(S,S)-reboxetine via a new (S)-2-(hydroxymethyl)morpholine preparation. Org. Lett., 2005, 7(5), 937-939.
|
[135] |
Abdel-Jalil, R.J.; Ali Shah, S.T.; Khan, K.M.; Voelter, W. A novel route towards the synthesis of stereospecific n-substituted chiral morpholines. Lett. Org. Chem., 2005, 2, 306-308.
|
[136] |
Pommer, E-H. Chemical structure-fungicidal activity relationships in substituted morpholines. Pestic. Sci., 1984, 15, 285-295.
|
[137] |
Wong, E.H.F.; Sonders, M.S.; Amara, S.G.; Tinholt, P.M.; Piercey, M.F.P.; Hoffmann, W.P.; Hyslop, D.K.; Franklin, S.; Porsolt, R.D.; Bonsignori, A.; Carfagna, N.; McArthur, R.A. Reboxetine: A pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol. Psychiatry, 2000, 47(9), 818-829.
|
[138] |
Dieckmann, H.; Stockmaier, M.; Kreuzig, R.; Bahadir, M.F. Simultaneous determination of fenpropimorph and the corresponding metabolite fenpropimorphic acid in soil. J. Anal. Chem., 1993, 345, 784-786. |
[139] |
Kaiho, T.; Kusano, K.; Taniyama, T. Benzyl alcohol derivatives or salts thereof. WO 2005023235 A1, 2005. |
[140] |
Bridger, G. J.; McEachern, E. J.; Skerlj, R.; Schols, D. Chemokine receptor binding heterocyclic compounds with enhanced efficacy. WO2004093817A2, 2004. |
[141] |
Horiuchi, Y.; Sone, T. Jpn. Kokai Tokkyo Koho JP 2004277337 A2, Oct 7, (2004). Chem. Abstr., 2004, 141325708 |
[142] |
Habashita, H.; Kokubo, M.; Shibayama, S.; Tada, H.; Tanihiro, T. Nitrogen-containing heterocyclic compound and pharmaceutical use thereof. WO 2004052862A1, 2004. |
[143] |
Sugihara, Y.; Iizawa, Y.; Baba, M. Cyclic amine compound, process for producing the same, and use. WO 2004026833A1, 2004. |
[144] |
Singh, N.; Sijwali, P.S.; Pandey, K.C.; Rosenthal, P.J. Plasmodium falciparum: Biochemical characterization of the cysteine protease falcipain-2′. Exp. Parasitol., 2006, 112(3), 187-192.
|
[145] |
Hirokawa, Y.; Kinoshita, H.; Tanaka, T.; Nakamura, T.; Fujimoto, K.; Kashimoto, S.; Kojima, T.; Kato, S. Pleuromutilin derivatives having a purine ring. Part 3: Synthesis and antibacterial activity of novel compounds possessing a piperazine ring spacer. Bioorg. Med. Chem. Lett., 2009, 19(1), 175-179.
|
[146] |
Fung, H.B.; Kirschenbaum, H.L.; Ojofeitimi, B.O. Linezolid: an oxazolidinone antimicrobial agent. Clin. Ther., 2001, 23(3), 356-391.
|
[147] |
Takeuchi, H.; Yatsugi, S.; Hatanaka, K.; Nakato, K.; Hattori, H.; Sonoda, R.; Koshiya, K.; Fujii, M.; Yamaguchi, T. Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity. Eur. J. Pharmacol., 1997, 329(1), 27-35.
|
[148] |
a)Szulawska, A.; Arkusinska, J.; Czyz, M. Accumulation of gamma-globin mRNA and induction of irreversible erythroid differentiation after treatment of CML cell line K562 with new doxorubicin derivatives. Biochem. Pharmacol., 2007, 73(2), 175-184. b)Jakubowska, J.; Wasowska-Lukawska, M.; Czyz, M. STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis. Eur. J. Pharmacol., 2008, 596(1-3), 41-49.
|
[149] |
Mesropyan, E.G.; Galstyan, A.S.; Avetisyan, A.A. Syntheses on the basis of 4-(Oxiran-2-ylmethyl)morpholine. Russ. J. Org. Chem., 2006, 42(12), 1845-1847.
|
[150] |
Daryaee, F.; Kobarfard, F.; Khalaj, A.; Farnia, P. Synthesis and evaluation of in vitro anti-tuberculosis activity of N-substituted glycolamides. Eur. J. Med. Chem., 2009, 44(1), 289-295.
|
[151] |
Dorsey, B.D.; Levin, R.B.; McDaniel, S.L.; Vacca, J.P.; Guare, J.P.; Darke, P.L.; Zugay, J.A.; Emini, E.A.; Schleif, W.A.; Quintero, J.C.; Anderson, P.S.; Huff, J.R.L. L-735,524: the design of a potent and orally bioavailable HIV protease inhibitor. J. Med. Chem., 1994, 37(21), 3443-3451.
|
[152] |
Thomas, R.C.; Cleek, G.J.; Hutchinson, D.K.; Yamada, H. Oxazolidinone antibacterial agent with tricyclic substituents. U.S. Patent 5, 1999. |
[153] |
Davies, D.T.; Markwell, R.E.; Pearson, N.D.; Takle, A.K. Quinoline derivatives as antibacterials. U.S. Patent 6,911,442, 2005. |
[154] |
Erskine, S.G.; Gwynn, M.; Pearson, N.D.; Wilding, E.I. Compounds and methods for the treatment of neoplastic disease. U.S. Patent 6, 803, 369, 2004. |
[155] |
Naylor, A.; Judd, D.B.; Lloyd, J.E.; Scopes, D.I.C.; Hayes, A.G.; Birch, P.J. A potent new class of kappa-receptor agonist: 4-substituted 1-(arylacetyl)-2-[(dialkylamino)methyl]piperazines. J. Med. Chem., 1993, 36(15), 2075-2083.
|
[156] |
Cunico, W.; Gomes, C.R.B.; Facchinetti, V.; Moreth, M.; Penido, C.; Henriques, M.G.; Varotti, F.P.; Krettli, L.G.; Krettli, A.U.; da Silva, F.S.; Caffarena, E.R.; de Magalhães, C.S. Synthesis, antimalarial evaluation and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, part 2. Eur. J. Med. Chem., 2009, 44(9), 3816-3820.
|
[157] |
Ananda Kumar, C.S.; Benaka Prasad, S.B.; Vinaya, K.; Chandrappa, S.; Thimmegowda, N.R.; Kumar, Y.C.; Swarup, S.; Rangappa, K.S. Synthesis and in vitro antiproliferative activity of novel 1-benzhydrylpiperazine derivatives against human cancer cell lines. Eur. J. Med. Chem., 2009, 44(3), 1223-1229.
|
[158] |
Drizin, I.; Gregg, R.J.; Scanio, M.J.; Shi, L.; Gross, M.F.; Atkinson, R.N.; Thomas, J.B.; Johnson, M.S.; Carroll, W.A.; Marron, B.E.; Chapman, M.L.; Liu, D.; Krambis, M.J.; Shieh, C.C.; Zhang, X.; Hernandez, G.; Gauvin, D.M.; Mikusa, J.P.; Zhu, C.Z.; Joshi, S.; Honore, P.; Marsh, K.C.; Roeloffs, R.; Werness, S.; Krafte, D.S.; Jarvis, M.F.; Faltynek, C.R.; Kort, M.E. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain. Bioorg. Med. Chem., 2008, 16(12), 6379-6386.
|
[159] |
Shami, P.J.; Saavedra, J.E.; Bonifant, C.L.; Chu, J.; Udupi, V.; Malaviya, S.; Carr, B.I.; Kar, S.; Wang, M.; Jia, L.; Ji, X.; Keefer, L.K. Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo. J. Med. Chem., 2006, 49(14), 4356-4366.
|
[160] |
Li, J.B.; Xia, L.; Wu, B.; Wang, T.; Jiang, Z.Z. Design, synthesis and biological estimation of 1-(benzoxazole-2-yl)piperazine and 4-(benzoxazole-2-yl)piperidine derivatives as potential α1-AR antagonists. Chin. Chem. Lett., 2008, 19, 1193-1195.
|
[161] |
Masson, M.; Holappa, J.; Hjalmarsdottir, M.; Runarsson, O.V.; Nevalainen, T.; Jarvinen, T. Antimicrobial activity of piperazine derivatives of chitosan. Carbohydr. Polym., 2008, 74, 566-571.
|
[162] |
Sharma, P.K. Antifungal, Antibacterial and Antioxidant activities of substituted Morpholinylbenzothiazine. Der Pharmacia Lettre., 2016, 8(11), 140-142. |
[163] |
Sharma, P.K. Antibacterial, Antifungal and Antioxidant activities of substituted pyrazolylbenzothiazines. Der Pharmacia Lettre, 2016, 8(11), 79-82. |
[164] |
Sharma, P.K. Antibacterial, Antifungal and Antioxidant activities of substituted 4H-1,4-benzothiazines. Pharma Chem., 2016, 8(11), 156-159. |
[165] |
Sharma, P.K. Antibacterial and Antifungal activity of Piperazinylbenzothiazine. Pharma Chem., 2016, 8(5), 191-193. |
[166] |
Sharma, P.K. Morpholinylbenzothiazine consider as bioactive compound. Der Pharmacia Lettre, 2016, 8(4), 86-90. |
[167] |
Sharma, P.K. Synthesis of Bioactive substituted pyrazolylbenzothiazinones. Res. Chem. Intermed., 2015, 41(9), 6141-6148.
|
[168] |
Sharma, P.K. Synthesis and Antimicrobial Activity of Morpholinyl/Piperazinylbenzothiazines. Med. Chem. Res., 2012, 21(8), 2072-2078.
|
[169] |
Sharma, P.K. Synthesis and Antimicrobial activity of Structurally flexible Heterocycles with the 1,4-Thiazine Heterosystem. Res. Chem. Intermed., 2011, 37(8), 1103-1111.
|
[170] |
Sharma, P.K. Synthesis and Antimicrobial activity of 2H-pyrimido [2,1-b]benzothiazol-2-ones. Res. Chem. Intermed., 2010, 36(8), 985-993.
|
[171] |
Sharma, P.K. One-pot, Multicomponent Sequential Synthesis of Benzothiazoloquinazolinones. Synth. Commun., 2010, 40(16), 2347-2352.
|
[172] |
Sharma, P.K. N-bridged bioactive heterocycles: Synthesis of 2-methyl-4H-pyrimido [2, 1-b] benzothiazol-4-ones. Res. Chem. Intermed., 2009, 35, 35-41.
|
[173] |
Sharma, P.K. Regioselective one-pot synthesis of 5-chloro-3-methyl-8-trifluoromethyl-4H-1,4-benzothiazines. Heterocycl. Commun., 2019, 15(2), 127-133. |
[174] |
Sharma, P.K. Synthesis of 2,4-diaryl-2, 3-dihydro-1, 5-benzothiazepines. Heterocycl. Commun., 2008, 14(3), 155-160. |
[175] |
Sharma, P.K. Synthesis, spectral, energetic and reactivity properties of phenothiazines: Experimental and computational approach. J. Chem. Pharm. Res., 2015, 7(11), 462-473. |
[176] |
Chattopadhyay, S.K. Recent advancement in the synthesis of 1,2- and 2,1-benzothiazines. Synth. Commun., 2018, 48(24), 3033-3078.
|
[177] |
Makhova, N.N. Progress in the chemistry of nitrogen-, oxygen- and sulfur-containing heterocyclic systems. Russ. Chem. Rev., 2020, 89(1), 55.
|
[178] |
Pathania, S.; Narang, R.K.; Rawal, R.K. Role of sulphur-heterocycles in medicinal chemistry: An update. Eur. J. Med. Chem., 2019, 180, 486-508.
|
[179] |
Jampilek, J. Heterocycles in Medicinal Chemistry. Molecules, 2019, 24(21), 3839.
|